In COVID-19, tocilizumab reduces all-cause mortality at 28 d. Fernando SM, Rochwerg B. Ann Intern Med 2021 Jun 1. doi: 10.7326/ACPJ202106150.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fernando SM, Rochwerg B. In COVID-19, tocilizumab reduces all-cause mortality at 28 d. Ann Intern Med 2021 Jun 1. doi: 10.7326/ACPJ202106150.
PMID: 34058104